Authors/Disclosures
|
Daniel Pastula, MD, MHS, FÂ鶹´«Ã½Ó³»
(University of Colorado, Department of Neurology)
|
Dr. Pastula has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Valneva. Dr. Pastula has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Divisha Raheja, MD, FÂ鶹´«Ã½Ó³»
(St. Lukes Neurology Associates)
|
Dr. Raheja has nothing to disclose. |
|
|
No disclosure on file |
|
Sydney Cash, MD
(Massachusetts General Hospital)
|
Dr. Cash has received stock or an ownership interest from Beacon Biosignals. |
|
Edward J. Kasarskis, MD, PhD, FÂ鶹´«Ã½Ó³»
(UK Healthcare)
|
The institution of Dr. Kasarskis has received research support from Healey Platform Trial Group. The institution of Dr. Kasarskis has received research support from Amylyx . The institution of Dr. Kasarskis has received research support from Alexion. The institution of Dr. Kasarskis has received research support from Woolsey . Dr. Kasarskis has a non-compensated relationship as a Director of ALSA-supported clinic at the University of Kentucky with ALS Association that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
|
|
No disclosure on file |
|
Joel C. Morgenlander, MD, FÂ鶹´«Ã½Ó³»
(Duke University Medical Center)
|
Dr. Morgenlander has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Duke University. |
|
|
No disclosure on file |
|
Marvin P. Rozear, MD, FÂ鶹´«Ã½Ó³»
|
No disclosure on file |
|
Laura Sams, MD
(University of Cincinnati and Cincinnati VA Medical Center)
|
No disclosure on file |
|
Arman Sabet, MD, FÂ鶹´«Ã½Ó³»
|
Dr. Sabet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Sabet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Sabet has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for BOD Australia. Dr. Sabet has stock in CSL. |
|
Richard S. Bedlack, MD, PhD, FÂ鶹´«Ã½Ó³»
|
Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AB Science. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ALS Hope Foundation. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amylyx. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Capvision. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Carespace. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clene Nanomedicine. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Compassionate Care ALS. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eikonoclastes. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Haim Pharma. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Care Strategy Partners. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for i3 Health. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Impossible Dream Machine. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InThought. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kaplan. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeyQuest. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Launch Bio. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH HealthCare. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Med-IQ. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicinova. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurosense. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime Â鶹´«Ã½Ó³». Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roon. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurosense. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for GenieUS Genomics. The institution of Dr. Bedlack has received research support from MediciNova. The institution of Dr. Bedlack has received research support from Healey Center. Dr. Bedlack has received publishing royalties from a publication relating to health care. |